On the Simulation of Ultra-Sparse-View and Ultra-Low-Dose Computed Tomography with Maximum a Posteriori Reconstruction Using a Progressive Flow-Based Deep Generative Model.
Hisaichi ShibataShouhei HanaokaYukihiro NomuraTakahiro NakaoTomomi TakenagaNaoto HayashiSusumu MoriPublished in: Tomography (Ann Arbor, Mich.) (2022)
Ultra-sparse-view computed tomography (CT) algorithms can reduce radiation exposure for patients, but these algorithms lack an explicit cycle consistency loss minimization and an explicit log-likelihood maximization in testing. Here, we propose X2CT-FLOW for the maximum a posteriori (MAP) reconstruction of a three-dimensional (3D) chest CT image from a single or a few two-dimensional (2D) projection images using a progressive flow-based deep generative model, especially for ultra-low-dose protocols. The MAP reconstruction can simultaneously optimize the cycle consistency loss and the log-likelihood. We applied X2CT-FLOW for the reconstruction of 3D chest CT images from biplanar projection images without noise contamination (assuming a standard-dose protocol) and with strong noise contamination (assuming an ultra-low-dose protocol). We simulated an ultra-low-dose protocol. With the standard-dose protocol, our images reconstructed from 2D projected images and 3D ground-truth CT images showed good agreement in terms of structural similarity (SSIM, 0.7675 on average), peak signal-to-noise ratio (PSNR, 25.89 dB on average), mean absolute error (MAE, 0.02364 on average), and normalized root mean square error (NRMSE, 0.05731 on average). Moreover, with the ultra-low-dose protocol, our images reconstructed from 2D projected images and the 3D ground-truth CT images also showed good agreement in terms of SSIM (0.7008 on average), PSNR (23.58 dB on average), MAE (0.02991 on average), and NRMSE (0.07349 on average).
Keyphrases
- deep learning
- low dose
- computed tomography
- image quality
- dual energy
- convolutional neural network
- contrast enhanced
- positron emission tomography
- optical coherence tomography
- high resolution
- randomized controlled trial
- high dose
- machine learning
- multiple sclerosis
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- air pollution
- ejection fraction
- mass spectrometry
- prognostic factors
- heavy metals
- health risk